A Kaplan-Meier survival analysis was carried out to determine the relationship between the expression of BUB1B, TTK, and BUB3 and the overall survival and recurrence-free survival of ovarian cancer patients treated with paclitaxel. Here, BUB1B is linked to ovarian cancer.